|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online 11 September 2008
doi: 10.1242/dev.027078
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Report |
MRC Centre for Developmental and Biomedical Genetics and Department of Biomedical Science, University of Sheffield, Sheffield S10 2TN, UK.
* Author for correspondence (e-mail: m.placzek{at}sheffield.ac.uk)
Accepted 12 August 2008
SUMMARY
In the developing chick hypothalamus, Shh and BMPs are expressed in a spatially overlapping, but temporally consecutive, manner. Here, we demonstrate how the temporal integration of Shh and BMP signalling leads to the late acquisition of Pax7 expression in hypothalamic progenitor cells. Our studies reveal a requirement for a dual action of BMPs: first, the inhibition of GliA function through Gli3 upregulation; and second, activation of a Smad5-dependent BMP pathway. Previous studies have shown a requirement for spatial antagonism of Shh and BMPs in early CNS patterning; here, we propose that neural pattern elaboration can be achieved through a versatile temporal antagonism between Shh and BMPs.
Key words: Shh, BMP, Neural pattern, Hypothalamus, Gli, Chick
INTRODUCTION
In the developing vertebrate central nervous system (CNS), cellular fate
and diversity are established through inductive interactions, mediated largely
through only a few families of signalling ligands
(Edlund and Jessell, 1999
;
Altman and Brivanlou, 2001; Ulloa and
Briscoe, 2007). A key question is how this limited repertoire of
signals can elicit the cellular diversity that is characteristic of the CNS?
One way in which this can be achieved is through the ability of a cell to
integrate inputs from multiple signalling pathways. In the ventral neural
tube, for example, the transcriptional response of cells to a key ventralising
signal, Shh, is modulated by both the Wnt and the BMP signalling pathways
(McMahon et al., 1998;
Liem et al., 2000;
Patten and Placzek, 2002;
Lei et al., 2006).
Much evidence has shown that the Hedgehog (Hh) and bone morphogenetic
protein (BMP) signalling ligands play key roles in regulating cell identities
in the neural tube (Ericson et al.,
1995; Lee and Jessell,
1999; Ho and Scott,
2002; Chizhikov and Millen,
2005; Liu and Niswander,
2005; Ulloa and Briscoe,
2007). Through most of the neuraxis, BMPs and Shh, which emanate
from dorsal and ventral regions, respectively, establish opposing spatial
gradients that govern dorsoventral patterning by regulating cell-intrinsic
factors (Edlund and Jessell,
1999; Briscoe et al.,
2000; Briscoe and Ericson,
2001; Liem et al.,
2000; Patten and Placzek,
2002; Wijgerde et al.,
2002; Jacob and Briscoe,
2003; Meyer and Roelink,
2003). However, although there is clear evidence that cells can
integrate BMP and Shh signalling, the mechanisms that underlie this integrated
response are less well defined. In particular, few studies have examined the
interaction of Shh and BMP signalling at the level of the Gli genes. In the
case of Shh, numerous lines of evidence have identified the Gli transcription
factors as key mediators of the cellular response to Shh. Shh promotes ventral
cell identities by antagonising the repressive activity of the Gli3 protein:
in the absence of Shh, specific ventral cell types fail to form, but they can
be rescued in Shh-null animals by the simultaneous inactivation of Gli3
(Litingtung and Chiang, 2000;
Persson et al., 2002;
Wijgerde et al., 2002;
Bai et al., 2004;
Lei et al., 2004;
Stamataki et al., 2005;
Blaess et al., 2006). However,
although recent evidence shows that BMP signalling can maintain Gli3
expression in dorsal regions of the neural tube
(Meyer and Roelink, 2003), no
study has yet shown that BMP signalling can initiate the expression of
Gli3.
In contrast to other regions of the neural tube, in the hypothalamus, Shh
and BMPs are expressed in a spatially overlapping, but temporally consecutive
manner (Dale et al., 1997;
Dale et al., 1999;
Ohyama et al., 2005;
Manning et al., 2006). Here,
we examine the mechanism by which this discrete signalling profile governs
downstream Gli effectors and hypothalamic transcriptional signatures. Our
studies show that Bmp7 operates in a dual manner to specify hypothalamic
progenitors, first through a temporal antagonism of Shh-Gli activator
function, which is mediated by Gli3 upregulation, and second, via Smad5
activation. We demonstrate that Shh signalling operates through the Gli
activator (GliA) to prevent Pax7 expression. Bmp7 signalling upregulates Gli3
and we demonstrate that the Gli3 repressor (Gli3R) can derepress Pax7
expression, but inefficiently. Robust derepression requires both Gli3R and
Smad5 activity. Together, our data reveal that BMPs can initiate Gli3
expression in the neural tube. In addition, they suggest that, in the CNS,
neural pattern elaboration can be achieved through the temporal integration of
antagonising Shh and BMP ligands.
MATERIALS AND METHODS
Immunolabelling
Chick embryos (n=5-10; each stage) and explants (n=5-20)
were examined as described previously
(Ohyama et al., 2005).
Antibodies used were: 5E1 anti-Shh mAb (1:50); anti-Pax7 mAb (1:50); anti-Lim1
(4F8); anti-Msx1/2 (4G1: 1:50) (all from DSHB); Kyo2-60 anti-Nkx2.1 polyclonal
antibody (1:2000); anti-Gsh polyclonal antibody (1:2000); NCL-Ki67-PKi67
anti-human (Novocastra, 1:3000); anti-Isl1 polyclonal antibody (1:800); AB3216
anti-RFP polyclonal antibody (Chemicon, 1:1000); anti-GFP polyclonal (BD
632576, 1:1000); anti-pSmad1/5/8 (Cell Signaling 95115, 1:100-1:500).
Secondary antibodies were conjugated to Cy3, FITC (Jackson ImmunoResearch,
1:200), Alexa fluor 594 or Alexa fluor 488 (Molecular Probes, 1:500), and
images taken using Spot RT software v3.2 (Diagnostic Instruments) or an
Olympus FV-1000 confocal.
In situ hybridisation
Embryos and explants were processed as described previously
(Ohyama et al., 2005;
Manning et al., 2006;
Borycki et al., 2000).
Explant dissection and culture
pHyp and prechordal mesoderm were dissected with Dispase (1 mg/ml) for 15
minutes at room temperature and explants were cultured in collagen gels
(Dale et al., 1999). Bmp7 and
chordin proteins were prepared as described
(Ohyama et al., 2005). To
block Shh or BMP signalling, cyclopamine (600 nM) and/or dorsomorphin (4
µM) were added into culture medium 24-36 hours after onset of culture and
continued for up to 6 days.
|
).
Plasmids used were: Gli1 (Sasaki et al.,
1999); pCAGGS-GFP (Das et
al.2006); pCAGGS-RFP (Das et
al., 2006); Smad5 (Ishida et
al., 2000); Gli3 repressor (Gli3R)
(Persson et al., 2002) and
pRFPRNAi-Luciferase (Luc RNAi) (Das et
al., 2006). Gli3 RNAi plasmid was designed to target the following
sequence: CCACATACATGGTGAGAAGAAA. RESULTS AND DISCUSSION
In the developing hypothalamus, Shh and BMPs show temporally regulated
wave-like expression patterns in ventral midline cells of the prechordal
mesoderm, hypothalamic floor plate and in the ventro-lateral hypothalamus. In
each cell group, Shh expression precedes that of Bmp7: they transiently
overlap, before Shh is downregulated (Fig.
1A,B,E,I,J,M,Q,R,U) (Dale et
al., 1997; Dale et al.,
1999; Ohyama et al.,
2005; Manning et al.,
2006). Shh is retained at high levels only in the ventrolateral
hypothalamus, in cells that span the lumen, with nuclei at the ventricular
zone (VZ) (Fig. 1Q,R). Two
outstanding issues are whether ventrally derived Bmp7 temporally opposes Shh
signalling to specify progenitors in the developing ventrolateral
hypothalamus, and, if so, how this is achieved.
To begin to examine whether BMP signalling may temporally antagonise Shh
signalling, we documented expression of recognised responses to the two
signals, generating a profile of their spatiotemporal activities. The
Shh-responsive genes Ptc1 and Gli1
(Epstein et al., 1996;
Goodrich et al., 1996;
Hynes et al., 1997;
Marigo and Tabin, 1996) show a
similar initial spatiotemporal profile to Shh itself: expression detected in
ventral-dorsal waves, extending from the hypothalamic floor plate at stage 10
to ventrolateral cells at stage 15-17 (Fig.
1C,D,K,L); at these stages, expression of Ptc1 and Gli1 extends
slightly more dorsally to that of Shh, a feature more pronounced at stages
22-25 (Fig. 1Q,S,T). The onset
of expression of the BMP-responsive genes Msx1/2 and pSmad1/5/8
(Liem et al., 1995;
Rios et al., 2004) in each
cell group appears to correlate with the downregulation of Shh and
Shh-responsive genes. Msx1/2 and pSmad1/5/8 are robustly detected in
hypothalamic floor-plate cells at stage 15-17, then in ventrolateral cells by
stage 22-25 (Fig.
1F,G,N,O,V,W). Together, this analysis is consistent with the idea
that BMP might antagonise Shh signalling in a temporal manner.
We reasoned, then, that additional progenitor markers that are usually dorsally restricted in the posterior CNS might show ventral expression patterns within the hypothalamus, and focused on expression of the general `dorsal' progenitor marker Pax7. Prior to stage 16, Pax7 is expressed at the forebrain roof plate, but is not observed in the ventral or ventrolateral hypothalamus (Fig. 1H,P). By contrast, by stage 25, Pax7 expression is detected in roof-plate cells (shown in Fig. 4E), but, additionally, a new domain of expression is detected in a set of progenitor cells in the ventrolateral Nkx2.1+ hypothalamus (Fig. 1A',D'). At stage 25, the ventrolateral Pax7+ cells occupy Shh-negative regions of the subventricular zone (SVZ), and are located within outermost regions of a broader Nkx2.1+ domain, and just lateral to Gsh+ cells (Fig. 1A'-D'); many cells co-express Nkx2.1 and Pax7, and some cells show co-expression of Gsh and Pax7 (Fig. 1A',E'). By stage 30, Pax7+ cells occupy a distinct domain (Fig. 1X). Double-labelling of Pax7 and a proliferation marker, Ki67, demonstrates that at stage 30, many Pax7+ cells are proliferating progenitors (Fig. 1F'). Consistent with this observation, they are segregated from postmitotic Isl1+ cells (Fig. 1G'). Together, these data show that Pax7 is upregulated in proliferating basal progenitors of the ventrolateral hypothalamus.
|
|
), can
mimic Bmp7 activity. Although not as efficient as Bmp7, cyclopamine
significantly upregulated Pax7 (n=10;
Fig. 2F,K). Together, these
experiments suggest that BMP exerts its effect, at least in part, by
antagonising Shh signalling.
The antagonistic effects of Shh and Bmp7 on Pax7 expression are reminiscent
of dorsoventral spinal cord patterning, where BMPs contribute to the
establishment of neural progenitor domains in dorsal and intermediate regions
by opposing ventrally derived Shh and repressing ventral progenitor identity
(Liem et al., 1995). The
mechanisms by which BMP and Shh signals antagonise each other's function are
diverse, but one point of intersection is at the Gli transcription factors.
The Gli3 repressor (Gli3R) opposes Shh-GliA signalling, governing dorsal
identity through the repression of Nkx2.2+ and derepression of Pax7
(Persson et al., 2002). It is
believed that in the prospective spinal cord, BMPs elicit their effects on
dorsoventral patterning by maintaining Gli3 expression
(Meyer and Roelink, 2003), but
the factors that govern initial expression of Gli3 remain unclear.
We therefore examined whether there is a correlation in BMP signalling and Gli3 expression in the hypothalamus. At stage 8-13, Gli3 is not detected in the ventral hypothalamus, although strong expression is detected in the dorsal and intermediate forebrain (Fig. 2L). However, just prior to Pax7 upregulation, Gli3 expression is observed, in a dynamic fashion in the ventral and ventro-lateral hypothalamus (Fig. 2M-O). To test whether Bmp7 can direct Gli3 expression, pHyp explants were cultured alone (n=8) or with Bmp7 (n=7) for 3-4 days. In the presence of Bmp7, Gli3 expression was detected (Fig. 2P,Q). Conversely, when stage 15 pHyp explants were cultured alone, until a stage 25 equivalent, Gli3 was detected. When identical stage 15 pHyp explants were cultured with chordin, Gli3 showed a marked downregulation (n=4 each; compare Fig. 2R with 2S), indicating that BMP is required to upregulate Gli3 in the hypothalamus.
|
) into the
ventrolateral hypothalamus. Gli1 overexpression prevented Pax7 upregulation
(n=5), whereas a control GFP-alone vector showed no significant
effect (n=5 each; Fig.
3A-D,J). We next tested whether, conversely, there is a
requirement for Gli3 repressor function for Pax7 expression, by performing
Gli3 knockdown experiments. A Gli3 siRNA knockdown construct
(Das et al., 2006),
efficacious in reducing Gli3 expression
(Fig. 3E,F), was electroporated
into the hypothalamus at stage 10-12 and embryos were analysed at stage 25-30.
When Gli3 was knocked down, the number of Pax7+ progenitors was markedly
reduced (n=6; Fig.
3G,H,J); this effect could be reversed through the simultaneous
electroporation of Gli3 RNAi and a Gli3 expression vector (n=6;
Fig. 3I,J). The knock-down of
Gli3 did not abolish hypothalamic cells, as expression of an additional
hypothalamic marker, Lim1 (Ohyama et al.,
2005), was unaltered by Gli3 knockdown (n=4;
Fig. 3K,L). A luciferase
knockdown construct did not affect Pax7+ cells (n=4;
Fig. 3M,N). Together, these
data suggest that Gli3 is required for Pax7 expression in the ventral
hypothalamus. Our experiments support the idea that the upregulation of Pax7 requires the temporal antagonism of Shh signalling by BMP-mediated upregulation of Gli3, but do not indicate whether this is sufficient. To examine this, we asked whether Gli3R can upregulate Pax7 in the hypothalamus, targeting electroporations into regions of the anterior/medial hypothalamus in which neither Gli3 nor Pax7 are normally observed. These experiments revealed that Gli3R can upregulate Pax7, but in an inefficient and spatially restricted manner. Ectopic Pax7 expression was detected only when the Gli3R construct was electroporated into regions close to endogenous Pax7+ domains, and then only in a subset of embryos (6/9: Fig. 4A,B).
The finding that Bmp7, but not Gli3R, can robustly upregulate Pax7 suggests
a complex action of Bmp7. We therefore asked whether the upregulation of Pax7
could be more robustly achieved through the simultaneous activation of the BMP
signalling pathway and repression of the Shh signalling pathway. A Smad5
activator (Smad5A), a downstream signalling component of BMPs
(Ishida et al., 2000), was
electroporated either alone or with Gli3R. Smad5A alone was unable to induce
ectopic Pax7+ cells (n=5; Fig.
4C,D), although it was able to efficiently induce Msx expression
(data not shown). However, co-electroporation of Gli3R and Smad5A resulted in
a very robust induction of Pax7+ cells, ectopic Pax7 expression detected in
electroporated cells throughout the dorsoventral axis (n=8/9;
Fig. 4E-H). These data suggest
that pSmad5 and Gli3R may operate in non-linear pathways, both of which are
required for Pax7 expression. In support of this, examination of
Smad5-electroporated embryos showed, indeed, that Gli3 is not upregulated by
Smad5 (n=9; Fig.
4I,J). Together, these data suggest the idea that a dual action of
BMP signalling specifies Pax7+ basal progenitors: a Smad5-independent
Bmp7-Gli3R pathway opposes the Shh-Gli1A pathway to de-repress Pax7 in the
ventrolateral hypothalamus; in addition, BMP signalling via pSmad5 is required
to activate Pax7 (Fig. 4K).
To test this hypothesis, we prevented signalling of both Bmp7 and Shh in
pHyp explants. We reasoned that if BMP signalling acts exclusively through Shh
antagonism, the effect of cyclopamine should be dominant over that of
dorsomorphin, an ALK2/3/6 inhibitor that blocks pSmad
(Yu et al., 2008), and Pax7+
cells should be retained. pHyp explants were exposed to a combination of
cyclopamine and dorsomorphin (n=9), and analysed for expression of
Gli3, pSmad5 and Pax7. Only Gli3 was upregulated in the presence of
cyclopamine and dorsomorphin (Fig.
4M,O), whereas all three were detected in pHyp explants exposed to
Bmp7 (Fig. 4L,N; n=9).
Scattered expression of pSmad5, and no expression of Gli3 were detected in
pHyp explants cultured alone (not shown). Together, these results support our
proposed model for a dual action of Bmp7 is mediating Pax7 upregulation in the
hypothalamus.
In conclusion, our analysis makes a number of key points. First, it
provides a novel insight into how cellular diversity can be achieved within
the embryo in response to a limited repertoire of signalling molecules. Our
study shows that, in addition to the well-accepted view that BMP signal
opposes Shh activity in a spatial manner
(Liem et al., 1995;
McMahon et al., 1998;
Liem et al., 2000;
Briscoe and Ericson, 2001;
Meyer and Roelink, 2003),
ventrally derived Bmp7 signalling can oppose Shh signalling in a temporal
manner to specify ventral progenitors within the hypothalamus. The deployment
of the two signals in this versatile temporal manner in turn leads to novel
modules of transcription factor expression, in order to achieve elaborate
cellular diversity (Edlund and Jessell,
1999; Ingham and Placzek,
2006; Blaess et al.,
2006). Our work adds to the growing body of data suggesting that
cell fate in the neural tube is governed through the temporal integration of,
and adaptation to, signalling ligands
(Stamataki et al., 2005;
Blaess et al., 2006;
Dessaud et al., 2007;
Patthey et al., 2008;
Tucker et al., 2008).
Our data suggest, further, that Pax7 is normally suppressed in early
progenitors that are exposed to Shh signalling, but that a BMP-mediated
upregulation of Gli3 leads to a repression of Shh signalling and subsequent
de-repression of Pax7 expression. Our study is the first to demonstrate an
upregulation of Gli3 by Bmp7. Previous experiments have shown that BMPs can
maintain Gli3 expression within dorsal regions of the presumptive spinal cord
(Meyer and Roelink, 2003); our
study extends these observations. A key question is how does BMP upregulate
Gli3 expression within the ventral hypothalamus? Several reports indicate
epistatic relationships between BMP and Wnt signalling (e.g.
Fuentealba et al., 2007), and
recent data have suggested that Wnt signalling can induce, or maintain, Gli3
expression (Alvarez-Medina et al.,
2008). However, we find no evidence that a canonical BMP/Wnt
signalling pathway is sufficient to induce Gli3 in the hypothalamus: first,
overexpression of pSmad5 does not lead to Gli3 upregulation; second,
inhibition of pSmad signalling by dorsomorphin does not eliminate Gli3
expression; third, although Wnt8b is expressed within a region of the
hypothalamus (Hollyday et al.,
1995), its expression does not match precisely that of pSmad1/5/8.
Our in vitro analyses, however, suggest some complexity to the upregulation of
Gli3 by Bmp7, as induction is limited to a small region within pHyp explants,
favouring the interpretation that only specific cell types are competent to
respond to BMP by upregulating Gli3. Potentially, different competence factors
enable different responses to pSmad5 signalling, making it difficult to
exclude entirely some role for pSmad activity in Gli3 upregulation. A second
possibility, though, is that Gli3 upregulation is mediated by a distinct
signalling pathway. Earlier reports raise the possibility that non-canonical
BMP signalling pathways may operate in the CNS
(Panchision et al., 2001).
Alternatively, Gli3 upregulation may be governed by a Tbx2-mediated pathway.
In previous work, we have demonstrated that a BMP-Tbx2 pathway leads to a
downregulation of Shh and then of Shh signalling pathway elements, including
Ptc1 and Gli1/2 (Manning et al.,
2006). Future experiments will determine whether Tbx2 leads to
Gli3 upregulation.
Our experiments reveal, however, that the repression of Shh signalling and upregulation of Gli3 expression are insufficient to drive Pax7, which instead requires additional BMP signalling. This suggests that a dual action of BMP signalling specifies Pax7+ basal progenitors in the ventrolateral hypothalamus: a Smad5-independent Bmp7-Gli3R pathway opposes the Shh-Gli1A pathway, and, in addition, a Smad5-dependent BMP signalling pathway is required to activate Pax7 (Fig. 4K).
Generally, our studies show insights into how complexity of cell patterning can be achieved within the CNS through the temporal restriction of key signalling factors. The sequential temporal exposure of hypothalamic progenitors to the `ventralising' influence of Shh and subsequently to the `dorsalising' influence of Bmp7 establishes specific transcription factor codes, in this case directing the differentiation of ventrolateral Pax7+ progenitors. Here, we focus on the importance of this temporal sequence in the specification of Pax7+ hypothalamic progenitors. However, they are clearly only a fraction of the basal progenitor pool: the existence of Ki67+/Pax7-progenitors implies that there are other late-arising ventral hypothalamic progenitors. Future studies will reveal whether they are also specified by the temporal antagonism of Shh and BMP signalling.
ACKNOWLEDGMENTS
We thank Miss P. Ellis and Mr C. Law for assistance and advice; S. A. Wilson for the siRNA plasmid; K. Miyazono for Smad5 expression plasmid; C. Emerson for Gli3 probe; M. Goulding for Gsh antibody; H. Edlund for Isl1 antibody; H. Sasaki for Gli1 expression plasmid; J. Briscoe for Gli3R expression plasmid; Mrs C. Hill and J. Sanderson in the Wellcome Trust-funded Microscopy Facility; and two anonymous reviewers for helpful comments. This study was supported by the Medical Research Council of Great Britain (M.P.).
REFERENCES
Altmann, C. R. and Brivanlou, A. H. (2001).
Neural patterning in the vertebrate embryo. Int. Rev.
Cytol. 203,447
-482.[Medline]
Alvarez-Medina, R., Cayuso, J., Okubo, T. and Marti, E.
(2008). Wnt canonical pathway restricts graded Shh/Gli patterning
activity through the regulation of Gli3 expression.
Development 135,237
-247.
Bai, C. B., Stephen, D. and Joyner, A. L.
(2004). All mouse ventral spinal cord patterning by hedgehog is
Gli dependent and involves an activator function of Gli3. Dev
Cell 6,103
-115.[CrossRef][Medline]
Borycki, A., Brown, A. M. and Emerson, C. P., Jr
(2000). Shh and Wnt signalling pathway converge to control Gli
gene activation in avian somites. Development
127,2075
-2087.[Abstract]
Blaess, S., Corrales, J. D. and Joyner, A. L.
(2006). Sonic hedgehog regulates Gli activator and repressor
functions with spatial and temporal precision in the mid/hindbrain region.
Development 133,1799
-1809.
Briscoe, J. and Ericson, J. (2001).
Specification of neuronal fates in the ventral neural tube. Curr.
Opin. Neurobiol. 11,43
-49.[CrossRef][Medline]
Briscoe, J., Pierani, A., Jessell, T. M. and Ericson, J.
(2000). A homeodomain protein code specifies progenitor cell
identity and neuronal fate in the ventral neural tube.
Cell 101,435
-445.[CrossRef][Medline]
Chizhikov, V. V. and Millen, K. J. (2005). Roof
plate-dependent patterning of the vertebrate dorsal central nervous system.
Dev. Biol. 277,287
-295.[CrossRef][Medline]
Dale, J. K., Vesque, C., Lints, T. J., Sampath, T. K., Furley,
A., Dodd, J. and Placzek, M. (1997). Cooperation of BMP7 and
SHH in the induction of forebrain ventral midline cells by prechordal
mesoderm. Cell 90,257
-269.[CrossRef][Medline]
Dale, J. K., Sattar, N., Heemskerk, J., Clarke, J. D. W.,
Placzek, M. and Dodd, J. (1999). Differential patterning of
ventral midline cells by axial mesoderm is regulated by BMP7 and chordin.
Development 126,397
-408.[Abstract]
Das, R. M., Van Hateren, N. J., Howell, G. R., Farrell, E. R.,
Bangs, F. K., Porteous, V. C., Manning, E. M., McGrew, M. J., Ohyama, K.,
Sacco, M. A. et al. (2006). A robust system for RNA
interference in the chicken using a modified microRNA operon. Dev.
Biol. 294,554
-563.[CrossRef][Medline]
Dessaud, E., Yang, L. L., Hill, K., Cox, B., Ulloa, F., Ribeiro,
A., Mynett, A., Novitch, B. G. and Briscoe, J. (2007).
Interpretation of the sonic hedgehog morphogen gradient by a temporal
adaptation mechanism. Nature
450,717
-720.[CrossRef][Medline]
Edlund, T. and Jessell, T. M. (1999).
Progression from extrinsic to intrinsic signalling in cell fate specification:
a view from the nervous system. Cell
96,211
-224.[CrossRef][Medline]
Epstein, D. J., Marti, E., Scott, M. P. and McMahon, A. P.
(1996). Antagonizing cAMP-dependent protein kinase A in the
dorsal CNS activates a conserved Sonic hedgehog signaling pathway.
Development 122,2885
-2894.[Abstract]
Ericson, J., Muhr, J., Jessell, T. M. and Edlund, T.
(1995). Sonic hedgehog: a common signal for ventral patterning
along the rostro-caudal axis of the neural tube. Int. J. Dev.
Biol. 39,809
-816.[Medline]
Fuentealba, L. C., Eivers, E., Ikeda, A., Hurtado, C., Kuroda,
H., Pera, E. M. and De Robertis, E. M. (2007). Integrating
patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal.
Cell 131,980
-993.[Medline]
Goodrich, L. V., Johnson, R. L., Milenkovic, L., McMahon, J. A.
and Scott, M. P. (1996). Conservation of the hedgehog/patched
signaling pathway from flies to mice: induction of a mouse patched gene by
Hedgehog. Genes Dev. 10,301
-312.
Ho, K. S. and Scott, M. P. (2002). Sonic
hedgehog in the nervous system: functions, modifications and mechanisms.
Curr. Opin. Neurobiol.
12, 57-63.[CrossRef][Medline]
Hollyday, M., McMahon, J. A. and McMahon, A. P.
(1995). Wnt expression patterns in chick embryo nervous system.
Mech. Dev. 52,9
-25.[CrossRef][Medline]
Hynes, M., Stone, D. M., Dowd, M., Pitts-Meek, S., Goddard, A.,
Gurney, A. and Rosenthal, A. (1997). Control of cell pattern
in the neural tube by the zinc finger transcription factor and oncogene Gli-1.
Neuron 19,15
-26.[CrossRef][Medline]
Incardona, J. P., Gaffield, W., Kapur, R. P. and Roelink, H.
(1998). The teratogenic veratrumalkaloid cyclopamine inhibits
sonic hedgehog signal transduction. Development
125,3553
-3562.[Abstract]
Ingham, P. W. and Placzek, M. (2006).
OrchestratingoOntogenesis: variations on a theme by Sonic hedgehog.
Nat. Rev. Genet. 7,841
-851.[CrossRef][Medline]
Ishida, W., Hamamoto, T., Kusanagi, K., Yagi, K., Kawabata, M.,
Takehara, K., Sampath, T. K., Kato, M. and Miyazono, K.
(2000). Characterization of bone morphogenetic protein-responsive
element in the mouse Smad6 promoter. J. Biol. Chem.
275,6075
-6079.
Jacob, J. and Briscoe, J. (2003). Gli proteins
and the control of spinal-cord patterning. EMBO Rep.
4, 761-765.[CrossRef][Medline]
Lee, K. J. and Jessell, T. M. (1999). The
specification of dorsal cell fates in the vertebrate central nervous system.
Annu. Rev. Neurosci. 22,261
-294.[CrossRef][Medline]
Lei, Q., Zelman, A. K., Kuang, E., Li, S. and Matise, M. P.
(2004). Transduction of graded Hedgehog signaling by a
combination of Gli2 and Gli3 activator functions in the developing spinal
cord. Development 131,3593
-3604.
Lei, Q., Jeong, Y., Misra, K., LI, S., Zelman, A. K., Epstein,
D. J. and Matise, M. P. (2006). Wnt signalling inhibitors
regulate the transcriptional response to morphogenetic Shh-Gli signalling in
the neural tube. Dev. Cell
11,325
-337.[CrossRef][Medline]
Liem, K. F., Jr, Tremml, G., Roelink, H. and Jessell, T. M.
(1995). Dorsal differentiation of neural plate cells induced by
BMP-mediated signals from epidermal ectoderm. Cell
82,969
-979.[CrossRef][Medline]
Liem, K. F., Jessell, T. M. and Briscoe, J.
(2000). Regulation of the neural patterning activity of sonic
hedgehog by secreted BMP inhibitors expressed by notochord and somites.
Development 127,4855
-4866.[Abstract]
Litingtung, Y. and Chiang, C. (2000).
Specification of ventral neural types is mediated by an antagonistic action
between Shh and Gli3. Nat. Neurosci.
10,979
-209.
Liu, A. and Niswander, L. A. (2005). Bone
morphogenetic protein signalling and vertebrate nervous system development.
Nat. Rev. Neurosci. 6,945
-954.[Medline]
Marigo, V. and Tabin, C. J. (1996). Regulation
of patched by sonic hdgehog in the developing neural tube. Proc.
Natl. Acad. Sci. USA 93,9346
-9351.
McMahon, J. A., Takada, S., Zimmerman, L. B., Fan, C. M.,
Harland, R. M. and McMahon, A. P. (1998). Noggin-mediated
antagonism of BMP signaling is require for growth and patternin of the neural
tube and somite. Genes Dev.
12,1438
-1452.
Manning, L., Ohyama, K., Saeger, B., Hatano, O., Wilson, S. A.,
Logan, M. and Placzek, M. (2006). Regional morphogenesis in
the hypothalamus. Dev. Cell
11,873
-885.[CrossRef][Medline]
Meyer, N. P. and Roelink, H. (2003). The
amino-terminal region of Gli3 antagonizes the Shh response and acts in
dorsoventral fate specification in the developing spinal cord. Dev.
Biol. 257,343
-355.[CrossRef][Medline]
Ohyama, K., Ellis, P., Kimura, S. and Placzek, M.
(2005). Directed differentiation of neural cells to hypothalamic
dopaminergic neurons. Development
132,5185
-5197.
Panchision, D. M., Pickel, J. M., Studer, L., Lee, S.-H.,
Turner, P. A., Hazel, T. G. and McKay, R. D. G. (2001).
Sequnetial actions of BMP receptors control neural precursor cell production
and fate. Genes Dev. 15,2094
-2110.
Patten, I. and Placzek, M. (2002). Opponent
activities of Shh and BMP signalling during floor plate induction in vivo.
Curr. Biol, 12,47
-52.[CrossRef][Medline]
Patthey, C., Gunhaga, L. and Edlund, T. (2008).
Early development of the central and peripheral nervous systems is coordinated
by Wnt and BMP signals. PLoS ONE 3:e1625
.
Persson, M., Stamataki, D., te, Welscher, P., Andersson, E.,
Böse, J., Rüther, U., Ericson, J. and Briscoe, J.
(2002). Dorsal-ventral patterning of the spinal cord requires
Gli3 transcriptional repressor activity. Genes Dev.
16,2865
-2878.
Rios, I., Alvarez-Rodriguez, R., Marti, E. and Pons, S.
(2004). BMP2 antagonises sonic hedgehog-mediated proliferation of
cerebellar granule neurones through Smad5 signalling.
Development 131,3159
-3168.
Sasaki, H., Nishizaki, Y., Hui, C.-C., Nakafuku, M. and Kondoh,
H. (1999). Regulation of Gli2 and Gli3 activities by an
amino-terminal repression domain: implication of Gli2 and Gli3 as primary
mediators of Shh signalling. Development
126,3915
-3924.[Abstract]
Stamataki, D., Ulloa, F., Tsoni, S. V., Mynett, A. and Briscoe,
J. (2005). A gradient of Gli activity mediates graded Sonic
Hedgehog signaling in the neural tube. Genes Dev.
19,626
-634.
Tucker, J. A., Mintzer, K. A. and Mullins, M. C.
(2008). The BMP signaling gradient patterns dorsoventral tissues
in a temporally progressive manner along the anteroposterior axis.
Dev. Cell 14,108
-119.[CrossRef][Medline]
Ulloa, F. and Briscoe, J. (2007). Morphogens
and the control of cell proliferation and patterning in the spinal cord.
Cell Cycle 6,2640
-2649.[Medline]
Wijgerde, M., McMahon, J. A., Rule, M. and McMahon, A. P.
(2002). A direct requirement for Hedgehog signaling for normal
specification of all ventral progenitor domains in the presumptive mammalian
spinal cord. Genes Dev.
16,2849
-2864.
Yu, P. B., Hong, C. C., Sachidanandan, C., Babitt, J. L., Deng,
D. Y., Hoyng, S. A., Lin, H. Y., Bloch, K. D. and Peterson, R. T.
(2008). Dorsomorphin inhibits BMP signals required for
embryogenesis and iron metabolism. Nat. Chem. Biol.
4, 33-41.[CrossRef][Medline]
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
